MSMR Names Its 2010 Biomedical Research Leaders
Ceremony in the State House to Recognize Researchers and Educators for Massachusetts Biomedical Research Day
Against the backdrop of Massachusetts Biomedical Research Day (October 21), the Massachusetts Society for Medical Research announces its 2010 Biomedical Research Leaders.
Senator Jack Hart of the First Suffolk district, Dr. Angie Warner, associate dean for academic affairs at the Tufts Cummings School of Veterinary Medicine, Mr. Henri Termeer, chairman, president and CEO of Genzyme Corporation and Dr. Saul Tzipori, Distinguished Professor at the Tufts Cummings School of Veterinary Medicine, are recognized by MSMR for the depth of their contributions to biomedical research and education in the state and the entire region.
Dr. Steven M. Niemi, Board Chair of the Massachusetts Society for Medical Research, said, “Biomedical Research Day celebrates the passion and work of every person who spends a career working for a better health for all. On this day MSMR is particularly pleased to recognize four outstanding individuals for their contributions throughout their careers. They are involved in research and education in very different ways, highlighting the diversity of talent that makes Massachusetts the premier location for biomedical research in the US.”
The four Biomedical Research Leaders will be honored at the Grand Staircase in the State House starting at 11:30 on Thursday, October 21.
Senator Hart’s award cites his “Legislative support of biomedical research within his district and throughout the Commonwealth.” Dr. Warner’s cites her “Her tireless commitment to educating the veterinarians and researchers of tomorrow.” The honor to Mr. Termeer recognizes “His unique tenure and leadership of biotechnology in Massachusetts and his commitment to a humanitarian mission.” And Professor Tzipori’s honors “His deep investigations of infectious diseases and his work to protect humans and animals from their scourge.”
Massachusetts Biomedical Research Day (October 21) was created by the Legislature in 2006 to celebrate the people and the benefits of biomedical research. Research performed here in the Commonwealth helps to save countless lives and improve health and healing for millions of people around the world. The research enterprise also contributes significantly to the State’s economy.
The Massachusetts Society for Medical Research (MSMR) is a non-profit educational and research support organization whose members are biotechnology firms, colleges and universities, hospitals and institutes, pharmaceutical companies, and others that support research.
The 2010 Biomedical Research Honorees
Senator John Hart currently represents approximately 160,000 people in his district, which includes Dorchester, South Boston, Mattapan and a portion of Hyde Park. The Senator crafted legislation for the Venture Development Center, which received $5,000,000 through Senator Hart’s 2006 Economic Stimulus Package, and is proving to be a great success attracting biotech start-ups. The VDC is also funding innovative cancer research, with $10,000,000 for the Center for Personalized Cancer Therapy, a partnership between UMass Boston and the Dana-Farber Harvard Cancer Center Institute.
In 2008, as Chair of the Joint Committee on Economic Development and Emerging Technologies, Senator Hart chaired the conference committee that drafted a $1 billion Life Sciences proposal. The bill was signed into law a few days later on June 16, 2008. In 2005, he worked closely with former Senate President Travaglini to author legislation to encourage embryonic stem cell research within a strict regulatory environment.
Children’s Hospital Boston presented Senator Hart with an award for his sponsorship of “An Act Relative to Biomedical Research,” which helps advance new clinical investigation into devastating congenital conditions and diseases that threaten the lives of newborns.
Senator Hart has also received, among numerous other recognitions: Legislator of the Year (Department of Mental Health) and Scholar Legislator Award (Massachusetts BioEd Foundation)
Prior to his career in politics, Senator Hart worked in community relations and sales. The Senator earned a BA from Tufts University, an MPA from Harvard University’s Kennedy School of Government, and a Juris Doctor at the New England School of Law.
Angeline Warner, DVM, DSc is the Associate Dean for Academic Affairs, Tufts University Cummings School of Veterinary Medicine.
Dr. Warner is an associate professor at the Cummings School of Veterinary Medicine at Tufts University. Prior to joining Tufts’ faculty full-time in 2003, Dr. Warned served as a course director there and simultaneously as an assistant professor at the Harvard University School of Public Health and Medical School.
After her bachelor’s studies at Vassar College, Dr. Warner earned a master’s in biological structure from the University of Miami, her doctor of veterinary medicine degree from the University of Florida, and a DSc in respiratory biology from the Harvard School of Public Health. She undertook an internship in large animal surgery and a residency in large animal medicine at the University of Pennsylvania’s New Bolton Center and became a diplomate of the American College of Veterinary Internal Medicine in 1986.
Prior to her work as an administrator, Dr. Warner’s research interests focused on lung function and healing, and she has received funding from the American Lung Association and the National Institutes for Health in this area. She received the NIH’s Clinical Investigator Award in 1995. Drawing on her research and clinical expertise, she has served as the course director for the veterinary school’s Veterinary Respiratory Pathophysiology course since 1990 and the director for the respiratory section of the general physiology course. She has written chapters in 10 books on pulmonary function and equine medicine, and has published and co-authored more than three dozen articles and abstracts in peer-reviewed journals.
Henri A. Termeer is Chairman, President and Chief Executive Officer, Genzyme Corporation.
He was appointed president of Genzyme Corporation in 1983, two years after the company's founding. He became its chief executive officer in 1985 and chairman in 1988. Under his leadership, Genzyme has grown to one of the world's leading biotechnology companies.
Widely acknowledged for his contributions to the biotechnology industry and health care field, Mr. Termeer is active in the areas of humanitarian assistance, policy issues, and innovation in providing access to health care. He serves on the board of directors of the Pharmaceutical Research and Manufacturers of America. He is a director of Massachusetts General Hospital, a board member of Partners HealthCare and a member of the board of fellows of Harvard Medical School.
Mr. Termeer is chairman of the Federal Reserve Bank of Boston's board of directors and a board member of Abiomed Inc. In 2008, he was appointed to Governor Patrick's Council of Economic Advisors, and he is a co-chair of the Leadership Council of the Mass. Life Sciences Collaborative. Mr. Termeer is also chairman emeritus of the New England Healthcare Institute, a nonprofit, applied research health policy organization he was instrumental in founding. At the Massachusetts Institute of Technology, he is a member of the Alfred P. Sloan Management Society. He is also a member of the board of MIT Corporation.
With a great dedication to improving global health, Mr. Termeer is a member of the board of directors of Project HOPE, an international nonprofit health education and humanitarian assistance. Mr. Termeer is a trustee for the Boston Museum of Science, and a director of the Biomedical Science Careers Program, which provides minority students with the support and guidance needed for successful careers in biomedical science. Mr. Termeer was inducted in 1999 as a Fellow in the American Academy of Arts and Sciences and was elected in 2005 to Honorary Fellowship at the British Royal College of Physicians.
Saul Tzipori, BVSc, PhD, DVSc, FRCVS, is the Distinguished Professor of Biomedical Sciences and Agnes Varis Professor in Science and Society, Tufts University Cummings School of Veterinary Medicine.
Dr. Saul Tzipori is a pioneer and leading investigator in the field of infectious diseases as evidenced by over 230 peer-reviewed articles in the highest quality journals (Science 2004; Nature, 1998, 2004), book chapters, books and review articles. He is the Director of the Division of Infectious Diseases (DID) at the Cummings School of Veterinary Medicine at Tufts University where he is a Distinguished Professor and holds the Agnes Varis University Chair in Science and Society. Under his leadership, the DID has become internationally recognized for its excellence in research of food and water borne diseases afflicting both animals and humans.
Dr. Tzipori’s nearly 40 year career in this field has led to seminal contributions, including creation of important animal models, and enhanced our understanding of diarrheal diseases in mammals focused on three infectious agents of public health importance: the enteric protozoa Cryptosporidium; a Microsporidium, Enterocytozoon bieneusi; and E. coli 0157:H7 (the cause of hemorrhagic colitis and hemolytic uremic syndrome or HUS). Dr. Tzipori has also made significant contributions in biodefense research through his work on Clostridium botulinum neurotoxins.